α1A受体阻滞剂所致射精障碍:无精液症与逆行射精的临床鉴别
本研究纳入42例因良性前列腺增大导致中重度下尿路症状且既往无射精障碍的初治男性患者,给予α1A受体阻滞剂治疗12周。通过问卷评估射精障碍,并检测高潮后中段尿精子及经直肠超声测量精囊体积。结果所有患者均报告射精障碍,无精液症患者高潮后精囊体积显著高于逆行射精患者(P<.001),提示两者可通过精囊体积与尿精子进行鉴别。
要点
- α1A受体阻滞剂治疗下尿路症状可导致射精障碍,所有42例患者均出现。
- 高潮后中段尿无精子(无精液症)者精囊体积显著更高。
- 高潮后中段尿有精子(逆行射精)者精囊体积显著更低。
核心结论
- 高潮后中段尿精子存在与否与精囊体积相关,支持α1A受体阻滞剂所致射精障碍存在逆行射精与无精液症双重病因。
研究设计与样本
- 前瞻性研究纳入42例因良性前列腺增大导致中重度下尿路症状的初治男性患者,给予α1A受体阻滞剂治疗12周。
主要发现
- 所有42例患者治疗后均报告射精障碍,4项男性性功能问卷和MSHQ-EjD-SF Q4评分显著升高(P<.001),MSHQ-EjD-SF Q1-3评分显著降低(P<.001)。
- 高潮后中段尿无精子(无精液症)患者的高潮后精囊体积显著高于有精子(逆行射精)患者(P<.001)。
临床怎么用
- 对于服用α1A受体阻滞剂后出现射精障碍的患者,可通过高潮后中段尿精子检测和经直肠超声测量精囊体积来鉴别无精液症与逆行射精。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the physiopathology of ejaculatory disorders (EjD) and discriminate between retrograde ejaculation (REj) and anejaculation (AEj) induced by α1A-blockers, through the association between the mean postorgasm seminal vesicle volume and the presence of sperm in midstream urine, in patients with moderate-to-severe lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement. MATERIALS AND METHODS: Therapy-naïve male patients with LUTS and without previous EjD were treated with α1A-blockers. Pre- and post-treatment EjD were investigated through question 4 of the 4-item Male Sexual Function questionnaire and the Male Sexual Health Questionnaire for Ejaculatory Dysfunction Short Form (MSHQ-EjD-SF). After 12 weeks, postorgasm urine was collected for sperm count and seminal vesicle volume was calculated through transrectal ultrasound. RESULTS: All 42 patients reported with EjD after treatment with α1A-blockers: 4-item Male Sexual Function questionnaire and MSHQ-EjD-SF Q4 scores were significantly higher (P <.001) and MSHQ-EjD-SF Q1-3 score was significantly lower (P <.001) than before. Postorgasm seminal vesicle volume was significantly higher in patients with postorgasm sperm-negative urine (AEj), and lower in patients with postorgasm sperm-positive urine (REj; P <.001). CONCLUSION: We clearly demonstrated an association between the presence of sperm in the midstream urine and seminal vesicle volume after orgasm, strongly confirming and differentiating the hypothesis of a dual etiology for EjD (REj vs AEj) secondary to α1A-blockers therapy for LUTS.
引用
- Pavone C, Abrate A, Li Muli P, et al. Can We Clinically Distinguish Anejaculation From Retrograde Ejaculation in Patients on α1A-Blockers Therapy for Lower Urinary Tract Symptoms? Urology. 2020. PMID: 32032683. doi:10.1016/j.urology.2020.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。